# Registry of the Combination of Antiplatelet Agents and Anticoagulant in Atrial Fibrillation Patients With a CHA2DS2VASc Score >1 Undergoing Percutaneous Coronary Interventions

> **NCT03012906** · — · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 500 (estimated)

## Conditions studied

- Percutaneous Coronary Intervention

## Interventions

- **OTHER:** the prevalence of ischemic events

## Key facts

- **NCT ID:** NCT03012906
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2019-01
- **Final completion:** 2019-07
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2017-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03012906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03012906, "Registry of the Combination of Antiplatelet Agents and Anticoagulant in Atrial Fibrillation Patients With a CHA2DS2VASc Score >1 Undergoing Percutaneous Coronary Interventions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03012906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*